Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia

Naif K Binsaleh,1,2 Reem Eltayeb,1 Subuhi Sherwani,2,3 Ali A Almishaal,4 Emad A Hindi,5 Husam Qanash,1,2 Abdulrahman S Bazaid,1 Abdulmajeed Owayed Alharbi,6 Mohammed B Bazaid,7 Shayaa Alsaadi Altamimi8 1Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha’i...

Full description

Bibliographic Details
Main Authors: Binsaleh NK, Eltayeb R, Sherwani S, Almishaal AA, Hindi EA, Qanash H, Bazaid AS, Alharbi AO, Bazaid MB, Altamimi SA
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/comparison-of-hematological-parameters-between-survivors-and-non-survi-peer-reviewed-fulltext-article-IJGM
_version_ 1827855040134512640
author Binsaleh NK
Eltayeb R
Sherwani S
Almishaal AA
Hindi EA
Qanash H
Bazaid AS
Alharbi AO
Bazaid MB
Altamimi SA
author_facet Binsaleh NK
Eltayeb R
Sherwani S
Almishaal AA
Hindi EA
Qanash H
Bazaid AS
Alharbi AO
Bazaid MB
Altamimi SA
author_sort Binsaleh NK
collection DOAJ
description Naif K Binsaleh,1,2 Reem Eltayeb,1 Subuhi Sherwani,2,3 Ali A Almishaal,4 Emad A Hindi,5 Husam Qanash,1,2 Abdulrahman S Bazaid,1 Abdulmajeed Owayed Alharbi,6 Mohammed B Bazaid,7 Shayaa Alsaadi Altamimi8 1Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha’il, Hail, Saudi Arabia; 2Medical and Diagnostic Research Centre, University of Ha’il, Hail, 55476, Saudi Arabia; 3Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia; 4Department of Speech-Language Pathology and Audiology, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia; 5Department of Clinical Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 6Laboratory Department, King Fahad General Hospital, Jeddah, Saudi Arabia; 7Pediatric Department, East Jeddah Hospital, Jeddah, Saudi Arabia; 8Quality Department, King Khalid Hospital, Hail, Saudi ArabiaCorrespondence: Naif K Binsaleh, Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Hail, P.O. Box 2440, Hail, Saudi Arabia, Tel +966505274077, Email n.binsaleh@uoh.edu.saObjective: Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a communicable disease transmitted through the respiratory route and bodily contact. The severity of infection and mortality rate of COVID-19 cases was significantly high in the initial stages of the pandemic. This study aims to investigate the hematological profile of COVID-19 survivors and non-survivors.Methods: This is a single-center retrospective study. A total of 108 hospitalized patients with laboratory-confirmed COVID-19 at East Jeddah Hospital between April and August 2020 were categorized into two groups based on outcome as survivors (n = 54) and non-survivors (n = 54). Hematological parameters and clinical profiles were analyzed and compared between the two groups.Results: The mean age and standard deviation of the survived (30– 71 years) and non-survived (33– 83) groups was 53 ± 10.8 and 57.9 ± 12.2 years, respectively, with no statistically significant difference in age between groups (p = 0.0513). Non-survivors had a significantly longer median length of stay in the intensive care unit (ICU) (7 days, IQR: 4.24 to 12) compared to survivors COVID-19 patients (5 days, IQR: 0 to 11.75) (p = 0.0151). For the survivors group, the participant’s age positively correlated with the length of hospital stay (r(52) = 0.21, p = 0.0005) and ICU length of stay r(52) = 0.18, p = 0.001). The median red blood cells (RBC) counts were significantly higher in the survived group (4.56x109/L, IQR: 4.02 to 5.11) in comparison with the non-survived (4.23x109/L, IQR: 3.75 to 4.23) group (p = 0.0011). All COVID-19 patients exhibited lymphocytopenia and a significant negative correlation was observed between the lymphocyte values and length of hospital stay among the survived group (p < 0.001) as well as length of ICU stay among the survived group (p < 0.0480). Disease-related mortality was significantly associated with reduced white blood cells (WBCs) (8.5× 109/L, IQR: 6.1 to 11.7) and reduced basophils (0.09%, IQR: 0.02 to 0.19). Additionally, statistically significant differences were found between the survived and non-survived groups with respect to prothrombin time (PT) (12.5 sec. vs 14 sec., p < 0.0001) and partial thromboplastin time (PTT) (31.8 sec. vs 40 sec., p = 0.0008).Conclusion: Hematological parameters can serve as valuable indicators to identify patients with severe COVID-19 and expected poor-prognosis/outcomes upon hospital admission. Cell counts of lymphocytes, WBCs, basophils and parameters such as PT and PTT can serve as clinical indicators to assess disease severity and predict progression to critical illness.Keywords: SARS-CoV-2, hematology, COVID-19
first_indexed 2024-03-12T11:39:27Z
format Article
id doaj.art-426920695c8247829e84633214423c59
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-03-12T11:39:27Z
publishDate 2023-08-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-426920695c8247829e84633214423c592023-08-31T19:08:36ZengDove Medical PressInternational Journal of General Medicine1178-70742023-08-01Volume 163955396286318Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi ArabiaBinsaleh NKEltayeb RSherwani SAlmishaal AAHindi EAQanash HBazaid ASAlharbi AOBazaid MBAltamimi SANaif K Binsaleh,1,2 Reem Eltayeb,1 Subuhi Sherwani,2,3 Ali A Almishaal,4 Emad A Hindi,5 Husam Qanash,1,2 Abdulrahman S Bazaid,1 Abdulmajeed Owayed Alharbi,6 Mohammed B Bazaid,7 Shayaa Alsaadi Altamimi8 1Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha’il, Hail, Saudi Arabia; 2Medical and Diagnostic Research Centre, University of Ha’il, Hail, 55476, Saudi Arabia; 3Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia; 4Department of Speech-Language Pathology and Audiology, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia; 5Department of Clinical Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 6Laboratory Department, King Fahad General Hospital, Jeddah, Saudi Arabia; 7Pediatric Department, East Jeddah Hospital, Jeddah, Saudi Arabia; 8Quality Department, King Khalid Hospital, Hail, Saudi ArabiaCorrespondence: Naif K Binsaleh, Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Hail, P.O. Box 2440, Hail, Saudi Arabia, Tel +966505274077, Email n.binsaleh@uoh.edu.saObjective: Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a communicable disease transmitted through the respiratory route and bodily contact. The severity of infection and mortality rate of COVID-19 cases was significantly high in the initial stages of the pandemic. This study aims to investigate the hematological profile of COVID-19 survivors and non-survivors.Methods: This is a single-center retrospective study. A total of 108 hospitalized patients with laboratory-confirmed COVID-19 at East Jeddah Hospital between April and August 2020 were categorized into two groups based on outcome as survivors (n = 54) and non-survivors (n = 54). Hematological parameters and clinical profiles were analyzed and compared between the two groups.Results: The mean age and standard deviation of the survived (30– 71 years) and non-survived (33– 83) groups was 53 ± 10.8 and 57.9 ± 12.2 years, respectively, with no statistically significant difference in age between groups (p = 0.0513). Non-survivors had a significantly longer median length of stay in the intensive care unit (ICU) (7 days, IQR: 4.24 to 12) compared to survivors COVID-19 patients (5 days, IQR: 0 to 11.75) (p = 0.0151). For the survivors group, the participant’s age positively correlated with the length of hospital stay (r(52) = 0.21, p = 0.0005) and ICU length of stay r(52) = 0.18, p = 0.001). The median red blood cells (RBC) counts were significantly higher in the survived group (4.56x109/L, IQR: 4.02 to 5.11) in comparison with the non-survived (4.23x109/L, IQR: 3.75 to 4.23) group (p = 0.0011). All COVID-19 patients exhibited lymphocytopenia and a significant negative correlation was observed between the lymphocyte values and length of hospital stay among the survived group (p < 0.001) as well as length of ICU stay among the survived group (p < 0.0480). Disease-related mortality was significantly associated with reduced white blood cells (WBCs) (8.5× 109/L, IQR: 6.1 to 11.7) and reduced basophils (0.09%, IQR: 0.02 to 0.19). Additionally, statistically significant differences were found between the survived and non-survived groups with respect to prothrombin time (PT) (12.5 sec. vs 14 sec., p < 0.0001) and partial thromboplastin time (PTT) (31.8 sec. vs 40 sec., p = 0.0008).Conclusion: Hematological parameters can serve as valuable indicators to identify patients with severe COVID-19 and expected poor-prognosis/outcomes upon hospital admission. Cell counts of lymphocytes, WBCs, basophils and parameters such as PT and PTT can serve as clinical indicators to assess disease severity and predict progression to critical illness.Keywords: SARS-CoV-2, hematology, COVID-19https://www.dovepress.com/comparison-of-hematological-parameters-between-survivors-and-non-survi-peer-reviewed-fulltext-article-IJGMsars-cov-2hematologycovid-19
spellingShingle Binsaleh NK
Eltayeb R
Sherwani S
Almishaal AA
Hindi EA
Qanash H
Bazaid AS
Alharbi AO
Bazaid MB
Altamimi SA
Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia
International Journal of General Medicine
sars-cov-2
hematology
covid-19
title Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia
title_full Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia
title_fullStr Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia
title_full_unstemmed Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia
title_short Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia
title_sort comparison of hematological parameters between survivors and non survivors covid 19 patients in saudi arabia
topic sars-cov-2
hematology
covid-19
url https://www.dovepress.com/comparison-of-hematological-parameters-between-survivors-and-non-survi-peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT binsalehnk comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT eltayebr comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT sherwanis comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT almishaalaa comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT hindiea comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT qanashh comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT bazaidas comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT alharbiao comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT bazaidmb comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia
AT altamimisa comparisonofhematologicalparametersbetweensurvivorsandnonsurvivorscovid19patientsinsaudiarabia